Novartis Consumer Health

Form 483 issued January 20, 2012 · Lincoln, Nebraska

Inspection
Dec 14, 2011 – Jan 20, 2012
Observations
3
Pages
23
FEI number
1911445

In short: On January 20, 2012, FDA issued a Form 483 with 3 observations to Novartis Consumer Health in Lincoln, Nebraska (FEI 1911445) after an inspection that ran Dec 14, 2011 – Jan 20, 2012. The investigators were Adree N. Anderson, Eric M. Miller, Thuy T. Nguyen and Warren J. Lopicka. Most observations concern quality system; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

Observations span 1 system, led by quality system.

Quality system1
Other1

Most cited: 21 CFR 211.22(d) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit are not…

  2. 03

    Investigations of an unexplained discrepancy did not extend to other batches of the same drug product…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Novartis Consumer Health?

FDA listed 3 observations on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected Novartis Consumer Health?

Adree N. Anderson, Eric M. Miller, Thuy T. Nguyen and Warren J. Lopicka are named on this Form 483, for the inspection of Dec 14, 2011 – Jan 20, 2012. Each investigator has a profile showing what they cite most.

When was Novartis Consumer Health inspected by FDA?

The inspection ran Dec 14, 2011 – Jan 20, 2012, and the Form 483 is dated January 20, 2012.

How do I get the full Form 483 for Novartis Consumer Health?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free